Biogen, Inc. (BIIB)
235.42
+2.60
(+1.11%)
USD |
NASDAQ |
Oct 15, 16:00
235.35
-0.08
(-0.03%)
After-Hours: 17:40
Biogen Price : 235.42 for Oct. 15, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 14, 2026 | 228.99 | 234.20 | 228.00 | 232.83 | 1.947M |
| Oct 13, 2026 | 230.34 | 231.04 | 226.71 | 228.90 | 1.049M |
| Oct 12, 2026 | 233.98 | 238.24 | 229.00 | 229.41 | 1.462M |
| Oct 09, 2026 | 220.62 | 227.20 | 219.22 | 225.71 | 815007.0 |
| Oct 08, 2026 | 220.15 | 223.08 | 215.73 | 218.43 | 1.339M |
| Oct 07, 2026 | 222.93 | 228.00 | 221.40 | 222.15 | 1.298M |
| Oct 06, 2026 | 224.53 | 225.97 | 218.00 | 222.89 | 1.008M |
| Oct 05, 2026 | 219.90 | 223.85 | 218.22 | 223.59 | 951320.0 |
| Oct 02, 2026 | 222.98 | 224.08 | 219.81 | 219.88 | 780428.0 |
| Oct 01, 2026 | 225.50 | 228.31 | 222.50 | 222.82 | 1.755M |
| Sep 30, 2026 | 227.23 | 229.36 | 225.50 | 225.88 | 1.553M |
| Sep 29, 2026 | 227.02 | 229.41 | 224.45 | 227.07 | 1.161M |
| Sep 28, 2026 | 225.87 | 230.49 | 225.51 | 228.69 | 1.332M |
| Sep 25, 2026 | 228.27 | 228.92 | 223.76 | 227.60 | 958031.0 |
| Sep 24, 2026 | 226.80 | 228.72 | 224.30 | 226.36 | 1.035M |
| Sep 23, 2026 | 226.94 | 229.19 | 222.36 | 227.53 | 1.494M |
| Sep 22, 2026 | 219.22 | 226.43 | 219.00 | 225.36 | 1.112M |
| Sep 21, 2026 | 216.14 | 221.92 | 214.59 | 219.07 | 928562.0 |
| Sep 18, 2026 | 219.05 | 220.17 | 215.26 | 215.50 | 2.636M |
| Sep 17, 2026 | 217.68 | 219.41 | 215.33 | 219.05 | 836707.0 |
| Sep 16, 2026 | 216.41 | 218.29 | 214.81 | 216.01 | 606493.0 |
| Sep 15, 2026 | 216.71 | 216.71 | 213.54 | 216.17 | 756047.0 |
| Sep 14, 2026 | 221.00 | 222.24 | 215.56 | 217.36 | 629931.0 |
| Sep 11, 2026 | 216.75 | 219.76 | 214.71 | 217.15 | 1.076M |
| Sep 10, 2026 | 209.92 | 216.70 | 208.93 | 215.43 | 936643.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ionis Pharmaceuticals, Inc. | 44.14 |
| AbbVie, Inc. | 283.29 |
| Gilead Sciences, Inc. | 157.47 |
| Amgen, Inc. | 434.01 |
| Johnson & Johnson | 252.91 |
Price Related Metrics
| PE Ratio | 41.69 |
| PS Ratio | 3.600 |
| Price to Book Value | 1.845 |
| Price to Free Cash Flow | 13.97 |
| Earnings Yield | 2.40% |
| Market Cap | 34.77B |
| Operating PE Ratio | 18.46 |
| Normalized PE Ratio | 25.77 |